日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The DCDC2/ENO1 axis promotes tumor progression and immune evasion in intrahepatic cholangiocarcinoma via activating FGL1-LAG3 checkpoint.

DCDC2/ENO1 轴通过激活 FGL1-LAG3 检查点促进肝内胆管癌的肿瘤进展和免疫逃逸

Wan Wenze, Li Yuan, Sun Wentao, Cheng Zewei, Ma Fen, Shen Sheng, Liu Houbao, Zhang Jiwei

Publication Trends of Research on Gallbladder Cancer During 2001-2021: A 20-Year Bibliometric Analysis

2001-2021年胆囊癌研究论文发表趋势:一项为期20年的文献计量分析

Sun, Wentao; Wan, Wenze; Gao, Zhihui; Suo, Tao; Shen, Sheng; Liu, Houbao

lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC

lncRNA RP11-147L13.8 通过调节胆囊癌中 c-Jun 蛋白的磷酸化来抑制转移和化疗耐药性。

Zheng, Bohao; Wang, Jiwen; Fan, Kun; Sun, Wentao; Wan, Wenze; Gao, Zhihui; Ni, Xiaojian; Zhang, Dexiang; Ni, Xiaoling; Suo, Tao; Liu, Han; Liu, Houbao; Shen, Sheng

Erratum: lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC

更正:lncRNA RP11-147L13.8 通过调节胆囊癌中 c-Jun 蛋白的磷酸化来抑制转移和化疗耐药性

Zheng, Bohao; Wang, Jiwen; Fan, Kun; Sun, Wentao; Wan, Wenze; Gao, Zhihui; Ni, Xiaojian; Zhang, Dexiang; Ni, Xiaoling; Suo, Tao; Liu, Han; Liu, Houbao; Shen, Sheng

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival

管腔型乳腺癌的一种新型预后生物标志物:CD39高表达与不良生存率相关

Ni, Xiaojian; Wan, Wenze; Ma, Jingjing; Liu, Xinyou; Zheng, Bohao; He, Zhixian; Yang, Weige; Huang, Lihong

Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts

建立和验证预测高危胃肠道间质瘤复发的预后列线图:对两个独立队列的回顾性分析

Lin, Yao; Wang, Ming; Jia, Jie; Wan, Wenze; Wang, Tao; Yang, Wenchang; Li, Chengguo; Chen, Xin; Cao, Hui; Zhang, Peng; Tao, Kaixiong